Role of Matrix Metalloproteases in Degradation of ECM
mTOR Signaling and Cancer Progression
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Jun 25, 2025

miRNA Expression Analyses in Prostate Cancer Clinical Tissues
Published on: September 8, 2015
Shuying Zhu1, Jing He1, Liliang Yin1
1Key Laboratory of Artificial Organs and Computational Medicine in Zhejiang Province, Shulan International Medical College, Zhejiang Shuren University, Hangzhou, PR China.
Epigenetic modifications and matrix metalloproteinases (MMPs) are key in prostate cancer (PCa) development and metastasis. Understanding these factors offers new avenues for early diagnosis, prognosis, and targeted therapies for PCa.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: